Home » Health Care

Biopharmaceutical Manufacturing and Distribution

Biotechnology Solutions for Everyday Life

Biotechnology, the combination of biology and technology, includes biologic applications, diagnostic tools and businesses that improve everyday life by providing solutions to some of life's most vexing problems.

Everywhere You Look Biotechnology Touches Your Life

Has a member of your family been vaccinated against hepatitis B? Do you know someone who has diabetes? Has anyone in your family had heart disease?

Fact Sheet on Drug Importation

Rx Drug Importation Poses Immediate and Incalculable Risk to American Patients (Apr. 19, 2004)

Fact sheet on S. 54, the Greater Access to Affordable Pharmaceuticals Act of 2003

In the early weeks of the 108th Congress, two Senate bills, S. 54 and S. 7, were introduced that embrace the "Greater Access to Affordable Pharmaceuticals Act of 2003" (GAAP), formerly known in the 107th Congress as S. 812

Biotechnology's Impact on Diseases of the Elderly: A White Paper

As people age they walk a minefield of life-threatening and debilitating diseases.

Letters, Testimony & Comments

BIO Comments on TTIP Negotiations
June 19 2013
The TTIP represents a profoundly important opportunity to advance progress in these areas. The following comments represent BIO’s initial suggestions for the formulation of negotiating objectives relevant to biotechnology.  
BIO Comments on the Indian DOP Report on Price Negotiation of Patented Drugs
June 19 2013
We understand the challenges that India faces with respect to healthcare and the innovative biotechnology industry stands ready to work with India to help address them.  
BIO Submits Comments on Brazil Rare Diseases Public Consultation
June 7 2013
BIO applauds the government of Brazil for taking steps towards developing regulatory requirements to ensure patients suffering from rare diseases have access to treatment.   
PBRER: BIO Comments on Postmarket Periodic Safety Reports in the International Conference on Harmonisation E2C(R2) Format
May 8 2013
BIO thanks the Food and Drug Administration for the opportunity to submit comments on the “Draft Guidance for Industry on Providing Postmarket Periodic Safety Reports in the International Conference on Harmonisation E2C(R2) Format .”
Drug Shortages: BIO Comments on Drug Shortages Task Force and Strategic Plan
March 14 2013
More Letters, Testimony & Comments →

Press Releases

Rx Open Activated to Report on Status of Pharmacies in Oklahoma
May 24 2013
Rx Response elevates to Alert status to address potential impact from Moore tornado on supply chain.
IFPMA, BIO and WADA Advance Anti-Doping Collaboration with the Launch of 2 Fields 1 Goal Campaign
July 23 2012
Groups issue booklet to help biotechnology and pharmaceutical companies identify pipeline medicines with doping potential.
BIO Endorses “Declaration Against Doping in Sport"
June 28 2011
BIO announced its endorsement of the “Joint Declaration on Cooperation in the Fight against Doping in Sport” between the World Anti-Doping Agency (WADA) and the International Federation of Pharmaceutical Manufactures and Associations (IFPMA).
Media Registration for the 2011 BIO International Convention Now Available Online
January 3 2011
The 2011 BIO International Convention will highlight the latest trends and the newest opportunities for executives, investors, scientists, policy leaders, and media from around the world.
BIO, Other Advanced Biofuels Organizations Ask Administration for Renewed Focus on Next Generation Biofuel Technologies
October 21 2010
More Press Releases →